Search

Your search keyword '"Rummel M"' showing total 228 results
Start Over Author "Rummel M"
228 results on '"Rummel M"'

2. Precision Nuclear-Spin Effects in Atoms: EFT Methods for Reducing Theory Errors

Author

Zalavari, L., Burgess, C. P., Hayman, P., and Rummel, M.

Subjects
High Energy Physics - Phenomenology, High Energy Physics - Theory, Physics - Atomic Physics
Abstract

We use effective field theory to compute the influence of nuclear structure on precision calculations of atomic energy levels. As usual, the EFT's effective couplings correspond to the various nuclear properties (such as the charge radius, nuclear polarizabilities, Friar and Zemach moments {\it etc.}) that dominate its low-energy electromagnetic influence on its surroundings. By extending to spinning nuclei the arguments developed for spinless ones in {\tt arXiv:1708.09768}, we use the EFT to show -- to any fixed order in $Z\alpha$ (where $Z$ is the atomic number and $\alpha$ the fine-structure constant) and the ratio of nuclear to atomic size -- that nuclear properties actually contribute to electronic energies through fewer parameters than the number of these effective nuclear couplings naively suggests. Our result is derived using a position-space method for matching effective parameters to nuclear properties in the EFT, that more efficiently exploits the simplicity of the small-nucleus limit in atomic systems. By showing that precision calculations of atomic spectra depend on fewer nuclear uncertainties than naively expected, this observation allows the construction of many nucleus-independent combinations of atomic energy differences whose measurement can be used to test fundamental physics (such as the predictions of QED) because their theoretical uncertainties are not limited by the accuracy of nuclear calculations. We provide several simple examples of such nucleus-free predictions for Hydrogen-like atoms., Comment: 71 pages plus appendices, 3 figures. This paper provides details for the results summarized in arXiv:2008.09719

Published
2020
Full Text
View/download PDF

3. Extended No-Scale Structure and $\alpha^{'2}$ Corrections to the Type IIB Action

Author

Pedro, F. G., Rummel, M., and Westphal, A.

Subjects
High Energy Physics - Theory
Abstract

We analyse a new ${\cal N}=1$ string tree level correction at ${\cal O}(\alpha'^2)$ to the K\"ahler potential of the volume moduli of type IIB Calabi-Yau flux compactification found recently by Grimm, Savelli and Weissenbacher~\cite{Grimm:2013gma} and its impact on the moduli potential. We find that it imposes a strong lower bound the Calabi-Yau volume in the Large Volume Scenario of moduli stabilisation. For KKLT-like scenarios we find that consistency of the action imposes an upper bound on the flux superpotential $|W_0|\lesssim 10^{-3}$, while parametrically controlled survival of the KKLT minimum needs extreme tuning of $W_0$ close to zero. We also analyse the K\"ahler uplifting mechanism showing that it can operate on Calabi-Yau manifolds where the new correction is present and dominated by the 4-cycle controlling the overall volume if the volume is stabilised at values $\mathcal{V} \gtrsim 10^3$. We discuss the phenomenological implication of these bounds on $\mathcal{V}$ in the various scenarios., Comment: 26 pages, 1 figure

Published
2013

7. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Author

Gaidzik, V I, Teleanu, V, Papaemmanuil, E, Weber, D, Paschka, P, Hahn, J, Wallrabenstein, T, Kolbinger, B, Köhne, C H, Horst, H A, Brossart, P, Held, G, Kündgen, A, Ringhoffer, M, Götze, K, Rummel, M, Gerstung, M, Campbell, P, Kraus, J M, Kestler, H A, Thol, F, Heuser, M, Schlegelberger, B, Ganser, A, Bullinger, L, Schlenk, R F, Döhner, K, and Döhner, H

Published
2016
Full Text
View/download PDF

9. P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS

Author

Lansigan, F., primary, Andorsky, D. J., additional, Coleman, M., additional, Yacoub, A., additional, Melear, J. M., additional, Fanning, S. R., additional, Kolibaba, K. S., additional, Reynolds, C., additional, Nowakowski, G. S., additional, Gharibo, M., additional, Ahn, J. R., additional, Li, J., additional, Rummel, M. J., additional, and Sharman, J. P., additional

Published
2022
Full Text
View/download PDF

10. Pottery from Motion – A Refined Approach to the Large-Scale Documentation of Pottery Using Structure from Motion

Author

Rummel Michael

Subjects
structure from motion, photogrammetry, 3d models, pottery, documentation, Archaeology, CC1-960
Abstract

In recent years, interest in the usage of computer-based methods in archaeology, especially regarding field documentation, has grown significantly. In 2021, Göttlich et al. presented a new large-scale three-dimensional (3D) capture method for the documentation of pottery using structure from motion. This method, however, was only tested on a very small sample set and never truly conducted in a large-scale documentation surrounding. Consequently, we decided to test this workflow on a large-scale basis during three field campaigns (March 2022, November 2022, and March 2023) in Lebanon, documenting more than 4,000 sherds in total. In this article, I will present the results and observations of these campaigns, critically discuss the workflow involved (documentation and processing), and propose a refined workflow for this methodology. This article focuses solely on the relevant documentation and 3D processing.

Published
2024
Full Text
View/download PDF

12. The effectiveness of an extra-curricular lecture for STI prevention and sexual education.

Author

Reinholz, M., Nellessen, T., Wei, E., Zippel, S., Fuchs, C., Kaemmerer, T., Clanner-Engelshofen, B. M., Frommherz, L. H., Rummel, M., French, L. E., and Stadler, P.-C.

Abstract

While the incidence of infections with the human immunodeficiency virus largely remained unchanged in Germany, an increase of other sexually transmitted infections (STIs) was observed. The aim was to analyse the effectiveness of our sexual education lecture for students in improving the awareness, knowledge and prevention of STIs. We conducted a cross-sectional survey after students had attended our extra-curricular lecture at the Department of Dermatology of the Ludwig-Maximilians-University of Munich, Germany (LMU). We compared the data with a previously performed study in which the same survey was carried out before the lecture had started. A total of 5866 questionnaires were included in the analysis. After attending the lecture significantly more students were aware of STIs (syphilis: 36.8% (before) vs. 63.5% (after); chlamydia: 30.5% vs. 49.3%; gonorrhoea: 22.4% vs. 38.2%; human papillomaviruses (HPV): 17.7% vs. 30.2%), the transmission pathways of STIs (oral: 36.6% vs. 82.6%; vaginal: 81.8% vs. 97.3%; anal: 42.8% vs. 94.0%; penile: 68.7% vs. 92.1%), knew that the HPV vaccination is directed against a virus (36.8% vs. 56.9%) and were interested in receiving a vaccination (57.7% vs. 78.8%). This study demonstrates the positive educative effects of our lecture for awareness and improved knowledge of STIs. To satisfy the need for a comprehensive sexual education, a combination of school and health facility-based programmes should be implemented as one single lecture cannot convey the entire information about STIs. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

14. INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Author

Sharman, J. P., primary, Melear, J. M., additional, Yacoub, A., additional, Fanning, S. R., additional, Andorsky, D. J., additional, Nowakowski, G. S., additional, Rummel, M. J., additional, Lansigan, F., additional, Li, J., additional, Ahn, J. R., additional, Gharibo, M., additional, and Coleman, M., additional

Published
2021
Full Text
View/download PDF

15. INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Author

. Lansigan, F, primary, . Parameswaran, V, additional, . Yacoub, A, additional, . Reynolds, C. M, additional, . Shao, S. H, additional, . Moore, S. G, additional, . Coleman, M, additional, . Andorsky, D. J, additional, . Nowakowski, G. S, additional, . Rummel, M. J, additional, . Li, J, additional, . Ahn, J. R, additional, . Gharibo, M, additional, and . Sharman, J. P, additional

Published
2021
Full Text
View/download PDF

25. Erratum: RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Author

Gaidzik, V I, Teleanu, V, Papaemmanuil, E, Weber, D, Paschka, P, Hahn, J, Wallrabenstein, T, Kolbinger, B, Köhne, C H, Horst, H A, Brossart, P, Held, G, Kündgen, A, Ringhoffer, M, Götze, K, Rummel, M, Gerstung, M, Campbell, P, Kraus, J M, Kestler, H A, Thol, F, Heuser, M, Schlegelberger, B, Ganser, A, Bullinger, L, Schlenk, R F, Döhner, K, and Döhner, H

Published
2016
Full Text
View/download PDF

32. MAGNIFY PHASE IIIB INTERIM ANALYSIS: FIRST REPORT OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

Author

Sharman, J., primary, Coleman, M., additional, Yacoub, A., additional, Melear, J., additional, Fanning, S., additional, Kolibaba, K., additional, Lansigan, F., additional, Reynolds, C., additional, Foon, K., additional, Li, J., additional, Llorente, M., additional, Rummel, M., additional, and Andorsky, D., additional

Published
2019
Full Text
View/download PDF

34. INTERIM ANALYSIS OF PHASE IIIB MAGNIFY STUDY OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

Author

Sharman, J., primary, Coleman, M., additional, Yacoub, A., additional, Melear, J., additional, Fanning, S., additional, Kolibaba, K., additional, Lansigan, F., additional, Reynolds, C., additional, Foon, K., additional, Li, J., additional, Llorente, M., additional, Rummel, M., additional, and Andorsky, D., additional

Published
2019
Full Text
View/download PDF

36. Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)

Author

Rummel, M., Buske, C., Hertenstein, B., Lerchenmüller, C. A., Koenigsmann, M., Lange, E., Reeb, M., Kaiser, U., Balser, C., Behringer, D., Dürig, Jan, Gaska, T., Maschmeyer, G., Schliesser, G., Burchardt, A., Barth, J., Kauff, F., Hinke, A., and Greil, R.

Subjects
Medizin
Published
2018

38. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

Author

Leblond, V. Kastritis, E. Advani, R. Ansell, S.M. Buske, C. Castillo, J.J. García-Sanz, R. Gertz, M. Kimby, E. Kyriakou, C. Merlini, G. Minnema, M.C. Morel, P. Morra, E. Rummel, M. Wechalekar, A. Patterson, C.J. Treon, S.P. Dimopoulos, M.A.

Abstract

Waldenström macroglobulinemia (WM) is a distinct B-cell lymphoproliferative disorder for which clearly defined criteria for the diagnosis, initiation of therapy, and treatment strategy have been proposed as part of the consensus panels of the International Workshop on Waldenström's Macroglobulinemia (IWWM). At IWWM-8, a task force for treatment recommendations was impanelled to review recently published and ongoing clinical trial data as well as the impact of new mutations (MYD88 and CXCR4) on treatment decisions, indications for B-cell receptor and proteasome inhibitors, and future clinical trial initiatives for WM patients. The panel concluded that therapeutic strategies in WM should be based on individual patient and disease characteristics. Chemoimmunotherapy combinations with rituximab and cyclophosphamide-dexamethasone, bendamustine, or bortezomib-dexamethasone provide durable responses and are still indicated in most patients. Approval of the BTK inhibitor ibrutinib in the United States and Europe represents a novel and effective treatment option for both treatment-naive and relapsing patients. Other B-cell receptor inhibitors, second-generation proteasome inhibitors (eg, carfilzomib), and mammalian target of rapamycin inhibitors are promising and may increase future treatment options. Active enrollment in clinical trials whenever possible was endorsed by the panel for most patients with WM. © 2016 by The American Society of Hematology.

Published
2016

40. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST-LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE.

Author

Fornecker, L., primary, Ou, F., additional, Dixon, J.G., additional, Casulo, C., additional, Hoster, E., additional, Hiddemann, W., additional, Sebban, C., additional, Morschhauser, F., additional, Marcus, R., additional, Hochster, H., additional, Rummel, M., additional, Hagenbeeck, A., additional, Kimby, E., additional, Herold, M., additional, Peterson, B.A., additional, Gyan, E., additional, Ladetto, M., additional, Zucca, E., additional, Nielsen, T., additional, Foon, K., additional, Vitolo, U., additional, Flowers, C.R., additional, Shi, Q., additional, and Salles, G., additional

Published
2017
Full Text
View/download PDF

41. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

Author

Haaß, Wiltrud, Kleiner, Helga, Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung, Morgner, A., Herbst, R., Matek, W., Lamberti, C., Zöller, T., Koch, B., Marth, T., Henzel, A., Wagner, S., Woska, E., German CML Study Group, Neumann, F., Hoffknecht, M. M., Illmer, T., Wolf, T., Ehninger, G., Kiani, A., Platzbecker, U., Aul, C., Badrakhan, C. D., Giagounidis, A., Wernli, M., Flaßhove, M., Henneke, F., Moritz, T., Simon, M., Müller, L. L., Janz, R., Eckart, M., Häcker, B., Rech, D., Mackensen, A., Bargetzi, M., Krause, S. W., Staib, P., Schlegel, F., Wätzig, K., Rudolph, R., Wattad, M., Baur, F. K., Heit, W., Beelen, D. W., Hüttmann, A., Fischer von Weikersthal, L., Novotny, J., Trenschel, R., Lindemann, A., Linck, D., Jäger, E., Al-Batran, Salah-Eddin, Ottmann, O. G., Serve, H., Reiber, T., Semsek, D., Gro, V., Waller, C., Kühnemund, A., Hoeffkes, H. G., Lambertz, H., Schulz, L., Tajrobehkar, K., Mittermüller, J., Rummel, M. J., Burchardt, A., Pralle, H., Müller, S., Runde, V., Klei, M., Westheider, J., Hoyer, A., Tessen, H. W., Hesse, A., Trümper, L., Binder, C., Schmidt, C. A., Hirt, C., Hahn, M., Sieber, M., Eschenburg, H., Wilhelm, S., Depenbusch, R., Rösel, S., Eimermacher, H., Spohn, C., Moeller, R., Schmitz, N., Nickelsen, M., Schlimok, G., Engel, E., Haatanen, T., Hollburg, W., Platz, D., Köster, H., Bokemeyer, C., Schafhausen, P., Grote-Metke, A., Bechtel, B., Hemeier, M., Reichert, D., Sosada, M., Ganser, A., Schlegelberger, B., Ho, A. D., Rohlfing, S., Dengler, J., Petersen, V., Porowski, P., Hahn, L., Dietzfelbinger, H., Weiß, Christel, Janssen, J., Gröschel, W., Bartholomäus, A., Pfreundschuh, M., Kemmerling, M., Hansen, R., Reeb, M., Link, H., Mahlmann, S., Mezger, J., Schatz, M., Furkert, J., Schmier, M., Gatter, J., Neumann, S., Heymanns, J., Steinmetz, H. T., Schmitz, S., Scheid, C., Planker, M., Frieling, T., Lollert, A., Mandel, T., Neise, M., Schröder, M., Greif, D., Kempf, B., März, W., Kremers, S., Müller, L., Hartmann, F., Heil, G., Goldmann, B., Majunke, P. J., Heinkele, P., Gregor, M., Theobald, M., Fischer, T., Thomas, S., Hensel, M., Plöger, C., Schuster, D., Brust, J., Hieber, U., Paliege, R., Hehlmann, R., Neubauer, A., Burchert, A., Graeven, U., Lange, C., Schmidt, G., Völkl, S., Schmidt, B., Hitz, H., Spiekermann, K., Reichert, P., Hiddemann, W., Haferlach, T., Haferlach, C., Schnittger, S., Stötzer, O., Scheidegger, C., Fischer, C., Berdel, W. E., Koppele, A., Hebart, H., Fuss, H., Snaga, A., Schmidt, P., Hoffmann, R., Reschke, D., Zirpel, I., Sauer, M., Lenk, G., Theilmann, L., Sandritter, B., Neben, K., Schenk, M., Dengler, R., Herr, W., Krause, S., Braun, B., Günther, E., Wacker, A., Pihusch, R., Baldus, M., Matzdorff, A., Staiger, H. J., Pollmeier, G., Grimminger, W., Geer, T., Schanz, S., Jür, C., Gassmann, W., Seitz, K., Kaesberger, J., Mück, R., Heim, D., Illerhaus, G., Denzlinger, C., Fiechtner, H., Springer, G., Hoffmann, D., Jacki, S. H., Kanz, L., Bross-Bach, U., Döhner, H., Stegelmann, F., Haferlach, Claudia, Gratwohl, A., Kalhori, N., Langer, W., Nusch, A., Wei, J., Kamp, T., Schadeck-Gressel, C., Schwerdtfeger, R., Josten, K. M., Klein, O., Fett, W., Tichelli, A., Strotkötter, H., Maintz, C., Groschek, M., Schlag, R., Elsel, W., Schüler, F., Dölken, G., Lindemann, H. W., Wolf, H. H., Schmoll, H. J., Korsten, S., Braumann, D., Hoelzer, P., Kleeberg, U., Hossfeld, D., Lange, E., Schubert, J., Weischer, H., Dürk, H. A., Kirchner, H. H., Bu, E C., Henesser, D., Sievers, B., Freier, W., Kaiser, U., Peest, D., Römer, E., Hermann, T., Fauser, A., Valverde, M. L., Menzel, J., Kemper, J., le Coutre, P., Hochhaus, A., La Rosée, P., Bentz, M., Prümmer, O., Kneba, M., Strack, U., Schoch, R., Severin, K., Stauch, M., Arnold, R., Karbach, U., Vehling-Kaiser, U., Köchling, G., Wei, U., Middeke, H., Neuhaus, T., Martin, H., Fetscher, S., Schmielau, J., Kämpfe, D., Ludwig, W. D., Uppenkamp, M., Wei, B., Thum, P., Wuillemin, W., Hofmann, W. K., Griesshammer, M., Tischler, H. J., Becker, M., Hanfstein, B., Müller, M., Ratei, R., Saußele, S., Lunscken, C., Kolb, H. J., Lutz, L., Hentrich, M., Nerl, C., Wendtner, C., Ladda, E., Gnad, M., Teutsch, C., Suna, H., Schmidt, E., Koschmieder, S., Falge, C., Wandt, H., Wilhelm, M., Köhne, C. H., Schweiger, C., Müller-Naendrup, C., Frühauf, S., Ludwig, F., Ranft, K., Dencausse, Y., Baake, G., Ritter, P. R., Kloke, O., Göttler, B., Schick, H. D., Schlegelberger, Brigitte, Urmersbach, A., Weidenhöfer, S., Weidinger, P., Wacker, D., Wehmeyer, J., Kreuser, E. D., Schlenska-Lange, A., Edinger, R., Andreesen, R., Wehmeier, A., Stahlhut, K., Blau, I., Käfer, G., Cerny, T., Hess, U., Priebe-Richter, C., Stange-Budumlu, O., Demandt, M., Freunek, G., Heidemann, E., Schleicher, J., Mergenthaler, H. G., Ihle, H., Boewer, C., Zeller, C., Laubenstein, H. P., Rendenbach, B., Clemens, M., Waladkhani, A. R., Forstbauer, H., Müller, F., Brettner, S., Raghavachar, A., Sperling, C., Kunzmann, V., Goebeler, M. E., Gmür, J., Schelenz, C., Koschuth, A., Kingreen, D., Heßling, J., Derwahl, K. M., Oldenkott, B., Müller, Martin C., Englisch, H. J., Thiel, E., Burmeister, T., Notter, M., de Wit, M., Rothaug, W., Büschel, G., Beyer, J., Dahmen, E., Hehlmann, Rüdiger, Biaggi, C., Lämmle, B., Friess, D., Baerlocher, G., Oppliger Leibundgut, E., Tobler, A., Just, M., Schäfer, E., Behringer, D., Brandt, M., Hofmann, Wolf-Karsten, Schmiegel, W., Vaupel, H. A., Verbeek, W., Ko, Y. D., Sauerbruch, T., Hahn-Ast, C., Janzen, V., Schmidt-Wolf, Ingo G. H., Trenn, G., Fabarius, Alice, van der Linde, M., Pommerien, W., Fritz, L., Krauter, J., Lordick, F., Fritsch, G., Pflüger, K. H., Diekmann, C., Kullmer, J., Doering, G., Seifarth, Wolfgang, Munzinger, H., Hertenstein, B., Peyn, A., Mayer, J., Zácková, D., Kujickova, J., Stier, S., Wejda, B., Möller-Faßbender, F., and Hänel, M.

Subjects
Adult, Aged, 80 and over, Chromosome Aberrations, Adolescent, Fusion Proteins, bcr-abl, Antineoplastic Agents, Chromosome Breakage, Middle Aged, Clonal Evolution, Young Adult, hemic and lymphatic diseases, Cell Line, Tumor, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Proteolysis, Imatinib Mesylate, Humans, Blast Crisis, Separase, Research Article, Aged
Abstract

PLoS ONE 10(6), e0129648 (2015). doi:10.1371/journal.pone.0129648, Published by PLoS, Lawrence, Kan.

Published
2015
Full Text
View/download PDF

42. Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

Author

Hutter-Kronke, M.-L., primary, Benner, A., additional, Dohner, K., additional, Krauter, J., additional, Weber, D., additional, Moessner, M., additional, Kohne, C.-H., additional, Horst, H. A., additional, Schmidt-Wolf, I. G. H., additional, Rummel, M., additional, Gotze, K., additional, Koller, E., additional, Petzer, A. L., additional, Salwender, H., additional, Fiedler, W., additional, Kirchen, H., additional, Haase, D., additional, Kremers, S., additional, Theobald, M., additional, Matzdorff, A. C., additional, Ganser, A., additional, Dohner, H., additional, and Schlenk, R. F., additional

Published
2016
Full Text
View/download PDF

43. A 3.55 keV Photon Line and its Morphology from a 3.55 keV ALP Line

Author

Cicoli, M, Conlon, JP, Marsh, MCD, and Rummel, M

Subjects
High Energy Physics - Phenomenology, High Energy Physics - Phenomenology (hep-ph), Cosmology and Nongalactic Astrophysics (astro-ph.CO), FOS: Physical sciences, Astrophysics::Cosmology and Extragalactic Astrophysics, Astrophysics::Galaxy Astrophysics, Astrophysics - Cosmology and Nongalactic Astrophysics
Abstract

Galaxy clusters can efficiently convert axion-like particles (ALPs) to photons. We propose that the recently claimed detection of a 3.55--3.57 keV line in the stacked spectra of a large number of galaxy clusters and the Andromeda galaxy may originate from the decay of either a scalar or fermionic $7.1$ keV dark matter species into an axion-like particle (ALP) of mass $m_{a} \lesssim 6\cdot 10^{-11}~{\rm eV}$, which subsequently converts to a photon in the cluster magnetic field. In contrast to models in which the photon line arises directly from dark matter decay or annihilation, this can explain the anomalous line strength in the Perseus cluster. As axion-photon conversion scales as $B^2$ and cool core clusters have high central magnetic fields, this model can also explains the observed peaking of the line emission in the cool cores of the Perseus, Ophiuchus and Centaurus clusters, as opposed to the much larger dark matter halos. We describe distinctive predictions of this scenario for future observations., Comment: 6 pages

Published
2014
Full Text
View/download PDF

44. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

Author

Dimopoulos, M.A. Kastritis, E. Owen, R.G. Kyle, R.A. Landgren, O. Morra, E. Leleu, X. García-Sanz, R. Munshi, N. Anderson, K.C. Terpos, E. Ghobrial, I.M. Morel, P. Maloney, D. Rummel, M. Leblond, V. Advani, R.H. Gertz, M.A. Kyriakou, C. Thomas, S.K. Barlogie, B. Gregory, S.A. Kimby, E. Merlini, G. Treon, S.P.

Abstract

Waldenström macroglobulinemia (WM) is a distinct B-cell lymphoproliferative disorder for which clearly defined criteria for the diagnosis, initiation of therapy, and treatment strategy have been proposed as part of the consensus panels of International Workshops on WM (IWWM). As part of the IWWM-7 and based on recently published and ongoing clinical trials, the panels updated treatment recommendations. Therapeutic strategy in WM should be based on individual patient and disease characteristics (age, comorbidities, need for rapid disease control, candidacy for autologous transplantation, cytopenias, IgM-related complications, hyperviscosity, and neuropathy). Mature data show that rituximab combinations with cyclophosphamide/ dexamethasone, bendamustine, or bortezomib/dexamethasone provided durable responses and are indicatedformostpatients. Newmonoclonalan-tibodies (ofatumumab), second-generation proteasome inhibitors (carfilzomib), mam-malian target of rapamycin inhibitors, and Bruton's tyrosine kinase inhibitors are promising and may expand future treatment options. A different regimen is typically recommended for relapsed or refractory disease. In selected patients with relapsed disease after long-lasting remission, reuse of a prior effective regimen may be appropriate. Autologous stem cell transplantation may be considered in young patients with chemosensitive disease and in newly diagnosed patients with very-high-risk features. Active enrollment of patients with WM in clinical trials is encouraged.

Published
2014

45. Rodents, lagomorphs and insectivores, from the middle Miocene hominoid locality of Çandir (Turkey)

Author

de Bruijn H., van den Hoek Ostende L., Kristkoiz-Boon E., Rummel M., Theocharopoulos C., Ünay E., and de Bruijn, H., Utrecht University, Faculty of Earth Sciences, Budapestlaan 4, Utrecht, Netherlands -- van den Hoek Ostende, L., National Natuurhistorisch Museum, P.O. Box 9517, Leiden, RA 2300, Netherlands -- Kristkoiz-Boon, E., Rotwandstrasse 33, Starnberg 82319, Germany -- Rummel, M., Römerstrasse 17, Weissenburg 91781, Germany -- Theocharopoulos, C., National University of Athens, Dept. of Earth Sciences, Athens, Panepistimiopolis 15784, Greece -- Ünay, E., Cümhüriyet University, Faculty of Geology, Sivas 58140, Turkey

Subjects
Middle Miocene, Turkey, parasitic diseases, Mammalia, Rodentia, Insectivora, Lagomorpha
Abstract

The small mammals from Çandir Loc. 2 are described. The rodents are represented by six families with thirteen species, the lagomorphs by one family with two species and the insectivores by four families with four species. The diverse rodent association with species that are endemic for the eastern Mediterranean area as well as species that are known from south western and central Europe does not allow an unequivocal correlation to the MN scale because the ranges of some of the latter do not overlap in the reference faunas. It is suggested that the traditional correlation of the Çandir fauna with MN6 has to be re-evaluated on the basis of the entire mammal content.

Published
2003

46. Towards explicit de Sitter vacua

Author

Louis, J., Rummel, M., Valandro, R., and Westphal, A.

Subjects
Astrophysics::Instrumentation and Methods for Astrophysics, Astrophysics::Cosmology and Extragalactic Astrophysics
Published
2012

48. A sufficient condition for IIB/F-theory dS vacua

Author

Rummel, M. and Westphal, A.

Subjects
Astrophysics::High Energy Astrophysical Phenomena, Astrophysics::Instrumentation and Methods for Astrophysics, Astrophysics::Solar and Stellar Astrophysics, Astrophysics::Cosmology and Extragalactic Astrophysics, Astrophysics::Galaxy Astrophysics
Published
2011

Catalog

Books, media, physical & digital resources
See catalog results